Livedo Reticularis: An Enigma

Area of Science:

• Dermatology
• Rheumatology
• Immunology

Background:

• Livedo reticularis (LV) is a common skin manifestation associated with Antiphospholipid Syndrome (APS).
• LV may indicate a poorer prognosis in APS, linked to thrombosis and pregnancy complications, regardless of antiphospholipid antibodies.
• Emerging evidence suggests a potential link between LV and accelerated atherosclerosis.

Purpose of the Study:

• To explore the association between livedo reticularis and seronegative antiphospholipid syndrome.
• To understand the prothrombotic and immunological underpinnings of livedo reticularis.
• To review the challenges in treating livedo reticularis, particularly cutaneous ulcers.

Main Methods:

• Review of existing literature on livedo reticularis and antiphospholipid syndrome.
• Analysis of clinical manifestations and pathological processes in livedo reticularis.
• Examination of treatment outcomes and challenges for livedo reticularis-associated ulcers.

Main Results:

• Livedo reticularis is associated with arterial/venous thrombosis and pregnancy morbidity, even in antiphospholipid antibody-negative individuals.
• Livedo reticularis may represent a seronegative form of antiphospholipid syndrome.
• Painful cutaneous ulcers are a challenging manifestation of livedo reticularis.

Conclusions:

• Livedo reticularis shares pathological similarities with APS, suggesting a potential link to seronegative APS.
• The condition involves complex prothrombotic and immunological factors.
• Effective treatment strategies for livedo reticularis, especially its ulcerative forms, remain a significant clinical challenge.